Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure

Front Immunol. 2021 May 3:12:645989. doi: 10.3389/fimmu.2021.645989. eCollection 2021.

Abstract

We describe the unique disease course and cure of SARS-CoV-2 infection in a patient with SCID and graft failure. In absence of a humoral immune response, viral clearance was only achieved after transfusion of convalescent plasma. This observation underscores the necessity of the humoral immune response for SARS-CoV-2 clearance.

Keywords: SARS-CoV-2; convalescent plasma; humoral immune response; remdesivir; severe combined immunodeficiency.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Viral / blood
  • COVID-19 / complications
  • COVID-19 / immunology
  • COVID-19 / therapy*
  • COVID-19 / virology
  • COVID-19 Serotherapy
  • Female
  • Graft Rejection / complications
  • Graft Rejection / immunology
  • Graft Rejection / virology
  • Humans
  • Immunization, Passive
  • SARS-CoV-2 / physiology*
  • Severe Combined Immunodeficiency / complications*
  • Severe Combined Immunodeficiency / immunology
  • Severe Combined Immunodeficiency / virology
  • Sustained Virologic Response
  • Viral Load
  • Virus Replication

Substances

  • Antibodies, Viral